摘要
目的探讨血清游离前列腺特异性抗原(FPSA)与总前列腺特异性抗原(TPSA)比值(F/T)在女性乳腺疾病中的临床应用价值。方法用电化学发光法(ECL)检测47例乳腺癌患者、34例乳腺良性增生患者和30例正常女性的血清FPSA、TPSA,并计算F/T比值,评价其在女性乳腺疾病的诊断和预后评估价值。结果以F/T比值为0.15为判断上限时,其阳性诊断率为46.8%,明显高于TPSA和FPSA单测时的阳性诊断率。结论血清F/T比值在女性乳腺疾病诊断和预后评估方面具有重要临床应用价值。
Objective To study the applied value of the ratio of the serum Free Prostate Specific Antigen(FPSA) and Total Prostate Specific Antigen(TPSA) in patients with female breast disease. Methods Electrochemiluminescence was perfomed to measure the serum FPSA and TPSA level in 47 patients of breast cancer, 34 women of benign breast diesae and 30 healthy women ;and evaluating the diagnostic and prognostic value of the ratio of the F/T to the breast disease. Results As F/T 0.15, the positive diagnosis rate was 46.8%. Its ratio was much higher than single to detect contents of FPSA or TPSA. Conclusion Detecting the ratio of F/T will be important helpful to the diagnostic and prognostic value to the breast disease.
出处
《医学研究与教育》
CAS
2012年第3期53-55,共3页
Medical Research and Education
基金
保定市科学技术研究与发展计划项目(11ZF039)